Case Study: Scienture achieves a successful FDA-approved liquid losartan launch with Responsory

Scienture launches first FDA-approved liquid losartan in a $292M market with Responsory

The pharmaceutical startup Scienture, LLC faced the challenge of launching Arbil, the first FDA-approved liquid losartan for patients unable to swallow pills. They needed to build market presence, educate healthcare providers unfamiliar with this option, and navigate strict regulatory compliance, all while differentiating their product in a competitive market. They partnered with the vendor Responsory to achieve a compliant, digital-first commercial launch.

Responsory developed an integrated marketing strategy with a comprehensive website as its core, tailored for healthcare professionals, patients, and caregivers. Their solution included specialized content, digital advertising, and a full suite of compliant assets. This approach established Arbil as the definitive liquid losartan solution, achieved strong SEO performance from launch, and enabled on-time market entry aligned with product availability for sales.

Scienture, LLC